Moderna (LIM:MRNA) 3-Year Book Growth Rate : 78.10% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Moderna 3-Year Book Growth Rate?

Moderna's Book Value per Share for the quarter that ended in Dec. 2023 was $36.27.

During the past 12 months, Moderna's average Book Value per Share Growth Rate was -27.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was 78.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 76.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 8 years, the highest 3-Year average Book Value per Share Growth Rate of Moderna was 142.30% per year. The lowest was 78.10% per year. And the median was 96.10% per year.

Competitive Comparison of Moderna's 3-Year Book Growth Rate

For the Biotechnology subindustry, Moderna's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moderna's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moderna's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Moderna's 3-Year Book Growth Rate falls into.

Moderna 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Moderna (LIM:MRNA) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Moderna 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Moderna's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna (LIM:MRNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (LIM:MRNA) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Mexico 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.